A Legal Firm’s View Of Investor Opportunities
Tapping Into Disruptive Medtech Trends
CMS patent attorneys Jane Hollywood and Rob Stephen say COVID-19 has not dented the enthusiasm of medtech start-up entrepreneurs from pushing back the technology boundaries in patient care delivery – in fact, they are getting younger.
You may also be interested in...
The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.
Johnson & Johnson's Ashley McEvoy explains how the global medtech business should change, seen through the lens of the coronavirus pandemic.
COVID-19 business volatility continues to impact the medtech industry, but Royal Philips is targeting modest comparable sales growth for 2020 after posting quarterly growth of 10%.